Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TNGX | AZN | AMGN | GILD | VRTX |
| Company | Tango Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 16.73 | 193.91 | 373.51 | 145.11 | 489.97 |
| High | 17.26 | 193.92 | 375.00 | 146.95 | 489.97 |
| Low | 16.50 | 190.96 | 367.76 | 143.89 | 476.57 |
| Latest | 17.15 | 192.50 | 367.79 | 145.21 | 478.13 |
| Change | +0.16 | -0.81 | -9.85 | -0.79 | -14.25 |
| % Change | +0.94% | -0.42% | -2.61% | -0.54% | -2.89% |
| Volume | 2,832,000 | 2,154,700 | 1,990,600 | 7,006,700 | 1,607,800 |
| 20-Day Average Volume | 3,912,675 | 2,077,440 | 2,559,845 | 6,873,900 | 1,518,010 |
| Previous Close | 16.99 | 193.31 | 377.64 | 146.00 | 492.38 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 13.62 | 202.27 | 376.49 | 148.81 | 478.25 |
| 20-Day Raw Stochastic | 92.97% | 13.48% | 21.39% | 17.21% | 47.97% |
| 20-Day Relative Strength | 70.91 | 46.39 | 51.63 | 52.33 | 51.80 |
| Weighted Alpha | +245.83 | +28.84 | +24.64 | +36.59 | +2.30 |
| Today's Opinion | 100% Buy | 56% Buy | 88% Buy | 88% Buy | 88% Buy |
| Previous Opinion | 100% Buy | 64% Buy | 100% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.90% since 03/05/26 | -2.54% since 03/05/26 | +0.05% since 03/05/26 | +0.05% since 03/05/26 | +3.76% since 03/05/26 |
| Low | 16.00 on 03/06/26 | 189.35 on 03/09/26 | 361.70 on 03/06/26 | 142.77 on 03/06/26 | 450.67 on 03/06/26 |
| High | 17.63 on 03/06/26 | 198.09 on 03/10/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 507.92 on 03/10/26 |
| 1-Month | |||||
| %Chg | +35.36% since 02/12/26 | -5.88% since 02/12/26 | +0.43% since 02/12/26 | -4.35% since 02/12/26 | +2.82% since 02/12/26 |
| Low | 10.80 on 03/02/26 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 450.67 on 03/06/26 |
| High | 17.63 on 03/06/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.95 on 02/13/26 | 507.92 on 03/10/26 |
| 3-Month | |||||
| %Chg | +83.42% since 12/12/25 | +7.15% since 12/12/25 | +15.75% since 12/12/25 | +20.61% since 12/12/25 | +5.77% since 12/12/25 |
| Low | 8.30 on 12/24/25 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 17.63 on 03/06/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| 6-Month | |||||
| %Chg | +162.63% since 09/12/25 | +20.98% since 09/12/25 | +33.07% since 09/12/25 | +26.77% since 09/12/25 | +21.19% since 09/12/25 |
| Low | 6.38 on 09/15/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 17.63 on 03/06/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,424,286 | 299,806,016 | 203,573,632 | 181,247,456 | 125,081,264 |
| Shares Outstanding, K | 142,689 | 1,550,908 | 539,068 | 1,241,421 | 254,034 |
| Annual Sales | 62,380,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -101,590,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 53,810,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 3,190,000,000 |
| Last Quarter Net Income | 15,880,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,191,100,000 |
| 60-Month Beta | 1.76 | 0.32 | 0.45 | 0.37 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.13 on 11/04/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | 05/11/26 | 05/05/26 | 05/07/26 | 04/23/26 | 05/04/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.29 | 17.18 | 18.23 | 30.40 |